Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches
In recent years, medication-related osteonecrosis of the jaw (MRONJ) became an arising disease due to the important antiresorptive drug prescriptions to treat oncologic and osteoporotic patients, as well as the use of new antiangiogenic drugs such as VEGF antagonist. So far, MRONJ physiopathogenesis...
Saved in:
Main Authors: | Thomas Lombard, Virginie Neirinckx, Bernard Rogister, Yves Gilon, Sabine Wislet |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/8768162 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adalimumab: Another Medication Related to Osteonecrosis of the Jaws?
by: Andrea Cassoni, et al.
Published: (2016-01-01) -
Radiographic Findings in Patients with Medication-Related Osteonecrosis of the Jaw
by: Camila Lopes Cardoso, et al.
Published: (2017-01-01) -
A Case of Brain Abscess Caused by Medication-Related Osteonecrosis of the Jaw
by: Kenji Yamagata, et al.
Published: (2016-01-01) -
Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the Literature
by: Eder Alberto Sigua-Rodriguez, et al.
Published: (2014-01-01) -
Conservative Surgical Management of Stage I Bisphosphonate-Related Osteonecrosis of the Jaw
by: Paolo Vescovi, et al.
Published: (2014-01-01)